$232.98 0.7%
Price vs. AI Score (Last 150 days)
Data gathered: April 16

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

Data Bits

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States.


Madrigal Pharmaceuticals
Price $232.98
Target Price Sign up
Volume 343,870
Market Cap $4.96B
Dividend Yield 0%
Revenue per Employee $0
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '23047M-47M-112M0-5.680
Q3 '23028M-31M-99M-99M-5.340
Q2 '23018M-21M-86M-83M-4.690
Q1 '23016M-19M-77M-74M-4.230
Q4 '22015M-15M-86M-84M-4.980

Insider Transactions View All

Taub Rebecca filed to sell 458,999 shares at $248.6.
April 10 '24
Taub Rebecca filed to sell 461,451 shares at $243.2.
April 10 '24
Taub Rebecca filed to sell 460,206 shares at $245.7.
April 10 '24
Taub Rebecca filed to sell 459,199 shares at $247.8.
April 10 '24
Taub Rebecca filed to sell 459,606 shares at $247.
April 10 '24

What is the Market Cap of Madrigal Pharmaceuticals?

The Market Cap of Madrigal Pharmaceuticals is $4.96B.

How Many People Work at Madrigal Pharmaceuticals?

As of our latest update, Madrigal Pharmaceuticals employed approximately 71 people worldwide. However, it's important to note that Madrigal Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Madrigal Pharmaceuticals' revenue per employee?

$0. To calculate Madrigal Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current price of Madrigal Pharmaceuticals?

Currently, the price of one share of Madrigal Pharmaceuticals is $232.98.

How can I analyze the MDGL stock price chart for investment decisions?

The MDGL stock price chart above provides a comprehensive visual representation of Madrigal Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Madrigal Pharmaceuticals shares. Our platform offers an up-to-date MDGL stock price chart, along with technical data analysis and alternative data insights.

Does MDGL offer dividends to its shareholders?

As of our latest update, Madrigal Pharmaceuticals (MDGL) does not offer dividends to its shareholders. Investors interested in Madrigal Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Madrigal Pharmaceuticals?

Some of the similar stocks of Madrigal Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.